MARGARET MINCHEW: Open Payments
NPI 1508938531 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 14 payments from 7 companies in 2025. Trend: 2023 $674 · 2024 $266 · 2025 $445
Food & beverage: $267Education: $178
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $178 |
| Sumitomo Pharma America, Inc. | 3 | $84 |
| ABBVIE INC. | 3 | $64 |
| Biogen, Inc. | 2 | $45 |
| Hologic Sales and Service, LLC | 2 | $39 |
| PFIZER INC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: VRAYLAR, MYFEMBREE, ZURZUVAE, GEMTESA, NOVASURE, APTIMA, ABRYSVO, Lynkuet.
Industry payments across GA — which companies pay providers there.
